Jasper Therapeutics JSPR Q1 2026 Beat Revenue NA EPS Exceeds by Significant Market Concentration Creates Room for Broader Equity Gains Analysts Suggest Diversification Potential Intel Stake Balloons to Over 50 Billion Trump Says US Should Have Demanded More CBAK Energy CBAT Slides 051 as Selling Pressure Mounts 20260515